Quantumzyme Responds to OTC Markets Designation and Denounces Unauthorized Promotion Activity
Quantumzyme Corp. responds to OTC Markets designation and unauthorized promotion activity, demonstrating commitment to market integrity and transparency. CEO Naveen Kulkarni emphasizes regulatory compliance and prompt resolution.
This news matters as it highlights Quantumzyme Corp.'s dedication to upholding market integrity, regulatory compliance, and transparent communication. Investors and stakeholders can gain insight into the company's proactive approach to addressing concerns and protecting its reputation in the market.
